`
Wednesday, 28 June 2017

Vaccines News

  • Iron oxide particle found in Hospira vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2015

    Singapore: Hospira has issued a voluntary recall of one lot of preservative-free Bupivacaine HCl Injection, due to visible particles embedded and free floating within a single-dose glass te...Read more

  • Watchdogs find foreign particle in Mylan cancer vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015

    Singapore: Mylan is recalling a series of intravenous injection due to the presence of visible foreign particulate matter that might cause potential of severe health consequences. The reca...Read more

  • China hep B market to touch $1.4 bn by 2024'

    Vaccines |  Analysis | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2016

    Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 million in 2014 to over $1.4 billion by 2024, representing a Compound Ann...Read more

  • Indonesia gets Bio Farma infant pentavalent vaccines

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013

    Singapore: The Indonesian Ministry of Health introduced a new immunization program and a pentavalent vaccine for babies aged two months-to-one year. The vaccine would provide immunity again...Read more

  • WHO stresses on effective immunization

    Vaccines |  Analysis | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2015

    Singapore: Progress towards global vaccination targets for 2015 is far off-track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million dea...Read more

  • What vaccines should Kate Middleton give her baby?

    Vaccines |  Analysis | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013

    The Duchess of Cambridge, Catherine (Kate) Middleton, has given birth to a baby and it will soon be time for the royal newborn to get immunized against the various scourges of the mortal wo...Read more

  • India must leverage on its private strength

    Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 04 Jun, 2012

    India recently decided to revive three of its public sector vaccine manufacturing units and a strong argument in support of their revival is that they will act as a buffer in times of medic...Read more

  • Malaria vaccine may be a reality soon!

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2015

    Singapore: A vaccine for malaria may soon be a reality as Melbourne researchers have made a significant discovery about how the body's immune system fights the infection. Researchers at the...Read more

  • China's Sinovac progresses to launch new vaccines

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2015

    Singapore: China's biopharmaceutical firm, Sinovac Biotech, is progressing on its pipeline vaccines and expects to bring the much needed vaccines for infectious diseases in the market soon....Read more

  • No proof of human-to-human H7N9 infection'

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2014

    Singapore: Amid fears of H7N9 turning into a pandemic in China with a new bout of cases, the country's National Health and Family Planning Commission released in a reassuring statement. Th...Read more

  • Tourists to soon get vaccine for 'Delhi Belly', typhoid

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013

    Singapore: Researchers at the University of Cambridge, UK, are developing a vaccine that would prevent bad stomach (or Delhi Belly as it is popularly called) or typhoid in tourists during v...Read more

  • Takeda expands Singapore operation

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2015

    Singapore: Japan headquartered Takeda Pharmaceutical has expanded its operations in Singapore in order to focus on emerging markets and to consolidate and streamline its Asia operations. D...Read more

  • Dengue incurs annual cost of $950 mn to SE Asia

    Vaccines |  Analysis | By Amrita Tejasvi | 0 Comment | 20 Jun, 2014

    Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east Asian countries every year and the countries are in desperate stage to...Read more

  • Ebola cure depends on biotech drug ZMapp

    Vaccines |  News | By Narayanan Suresh | 0 Comment | 07 Aug, 2014

    Strange as it may sound, the dreaded tobacco plant blamed for millions of deaths of cigarette smokers could emerge as the savior in producing the only working cure against Ebola. A small Am...Read more

  • EU reviews Sanofi's 4-in-1 Influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 12 Apr, 2013

    Singapore: Sanofi Pasteur has been accepted for review in the European Union for a quadrivalent (four-strain) formulation of Vaxigrip. The file has been accepted for review by France's Agen...Read more

  • Admedus increases share in Ian Frazer vaccine tech

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014

    Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, has increased its ownership in Admedus Vaccines, the platform vaccine...Read more

  • Are declining Ebola cases a challenge for clinical studies?

    Vaccines |  Analysis | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2015

    Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials of investigational treatments for the disease, as it will be more diff...Read more

  • BMS releases $3.5 mn fund for Hep B&C in India, China

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2014

    Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatitis B virus (HBV) and hepatitis C virus (HCV) in India and China. The ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls